Ophthalmology

Patients with neovascular age-related macular degeneration (nAMD) experienced improvements in central macular thickness and subretinal and intraretinal fluid after switching.

The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the duration is not approved.

Excessive use of digital devices and mental health issues can both contribute to the development of dry eye syndrome.

The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish efficacy, according to the FDA.

Both refractive and corneal astigmatism saw an increase in prevalence in children after the COVID-19 pandemic, with corneal changes potentially playing a part.

The topical treatment had no significant effect on total or central corneal fluorescence staining score.

Clinical trials for diabetic macular edema (DME) continue to see disparities in enrollment.

Perfluorohexyloctane ophthalmic solution had high treatment satisfaction in those who took it for dry eye.

Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal intraocular lenses.

Signs and symptoms of age-related macular degeneration (AMD) are important to spot to prevent further deterioration of sight.

Wet age-related macular degeneration (AMD) can be managed using brolucizumab due to its efficacy.

The ranibizumab injection delivered through an implant device could be administered in a convenient schedule twice per year for the treatment of diabetic macular edema (DME).

A rapid correction of hyperglycemia could be associated with ophthalmic complications based on several cases.

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the resveratrol oral supplement.

Although most of the innovation in treatment has come in the past decade, new treatments for glaucoma are still being tested, albeit at a slower pace.

Patients with visual impairments face major physical and financial barriers when seeking emergency care.

Calcitonin gene-related peptide (CGRP) and substance P (SP) had correlations with symptoms and signs of dry eye disease.

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD.

Patients with a foveal bulge had significantly enhanced visual acuity if they also had resolved diabetic macular edema (DME) or retinal vein occlusion (RVO).

Glaucoma can cause damage to the optic nerve if left untreated, making frequent eye appointments vital for catching it quickly.

The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was different in people with primary open angle glaucoma and pseudoexfoliation glaucoma.

When compared with auditory stimulus, patients with glaucoma had slower response times to visual stimulus.

Although intravitreal faricimab helped to decrease central subfield thickness (CST) in patients with eyes previously treated for neovascular age-related macular degeneration, best corrected visual acuity showed no sign of improvement.

Articles covering FDA approvals, dry eye disease, and how eye diseases may be linked to falls were among the top 5 most-read articles of 2024.